Key to preventing runaway inflammation in patients with seve

A treatment to prevent runaway inflammation in patients with severe COVID-19 is a step closer after a University of Queensland-led study into how immune cells respond to the virus.

Related Keywords

Kate Schroder , Larisa Labzin , Sarah Londrigan , Emily Henderson , Uq Institute For Molecular Bioscience , Peter Doherty Institute For Infection , Research Council , National Health , Professor Kate Schroder , Molecular Bioscience , Peter Doherty Institute , Medical Research Council , Chronic , Inflammation , Covid 19 , Drugs , Immune Response , Immune System , Immunity , Research , Cars , Ars Cov 2 , Virus ,